Cargando…

Host-targeting therapies for hepatitis C virus infection: current developments and future applications

Chronic hepatitis C virus (HCV) infection is a leading cause of chronic liver diseases and hepatocellular carcinoma (HCC) worldwide. In the past few years, anti-HCV therapies have undergone a revolution with the approval of multiple direct-acting antivirals (DAAs), which enable interferon-free treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crouchet, Emilie, Wrensch, Florian, Schuster, Catherine, Zeisel, Mirjam B., Baumert, Thomas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871046/ https://www.ncbi.nlm.nih.gov/pubmed/29619090 http://dx.doi.org/10.1177/1756284818759483

Ejemplares similares

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection
por: Zeisel, Mirjam B., et al.
Publicado: (2015)

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
por: Wrensch, Florian, et al.
Publicado: (2018)

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes
por: Verrier, Eloi R., et al.
Publicado: (2016)

Composite vector formulation for multiple siRNA delivery as a host targeting antiviral in a cell culture model of hepatitis C virus (HCV) infection†
por: Crouchet, E., et al.
Publicado: (2017)

CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies
por: Zona, Laetitia, et al.
Publicado: (2014)

Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
por: Goto, Kaku, et al.
Publicado: (2020)

Liver cell circuits and therapeutic discovery for advanced liver disease and cancer
por: Crouchet, Emilie, et al.
Publicado: (2021)

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection
por: Verrier, Eloi R., et al.
Publicado: (2016)

Combined small molecule and loss-of-function screen uncovers estrogen receptor alpha and CAD as host factors for HDV infection and antiviral targets
por: Verrier, Eloi R, et al.
Publicado: (2020)

Adaptive Immunity to Hepatitis C Virus
por: Zeisel, Mirjam B., et al.
Publicado: (2009)

Hepatitis C virus infection and related liver disease: the quest for the best animal model
por: Mailly, Laurent, et al.
Publicado: (2013)

Neutralizing Antibodies and Pathogenesis of Hepatitis C Virus Infection
por: Fafi-Kremer, Samira, et al.
Publicado: (2012)

Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Zeisel, Mirjam B., et al.
Publicado: (2021)

Mapping Determinants of Virus Neutralization and Viral Escape for Rational Design of a Hepatitis C Virus Vaccine
por: Keck, Mei-Le, et al.
Publicado: (2018)

Targeting the Host for New Therapeutic Perspectives in Hepatitis D
por: Turon-Lagot, Vincent, et al.
Publicado: (2020)

Hepatitis B virus compartmentalization and single-cell differentiation in hepatocellular carcinoma
por: Jühling, Frank, et al.
Publicado: (2021)

Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux
por: Crouchet, Emilie, et al.
Publicado: (2017)

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
por: Roehlen, Natascha, et al.
Publicado: (2020)

Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process
por: Colpitts, Che C., et al.
Publicado: (2020)

Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
por: Xiao, Fei, et al.
Publicado: (2014)

Non-Coding RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma
por: Plissonnier, Marie-Laure, et al.
Publicado: (2018)

The major form of hepatitis C virus alternate reading frame protein is suppressed by core protein expression
por: Wolf, Marie, et al.
Publicado: (2008)

Adaptation of Hepatitis C Virus to Mouse CD81 Permits Infection of Mouse Cells in the Absence of Human Entry Factors
por: Bitzegeio, Julia, et al.
Publicado: (2010)

Hepatitis B virus–host interactions and novel targets for viral cure
por: Ligat, Gaëtan, et al.
Publicado: (2021)

A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission
por: Fofana, Isabel, et al.
Publicado: (2013)

Hepatitis C Virus, Cholesterol and Lipoproteins — Impact for the Viral Life Cycle and Pathogenesis of Liver Disease
por: Felmlee, Daniel J., et al.
Publicado: (2013)

Genotype 1 Hepatitis C Virus Envelope Features That Determine Antiviral Response Assessed through Optimal Covariance Networks
por: Murray, John M., et al.
Publicado: (2013)

Hepatitis C virus: current concepts and future challenges
por: Klenerman, P., et al.
Publicado: (2012)

Signalome-wide assessment of host cell response to hepatitis C virus
por: Haqshenas, Gholamreza, et al.
Publicado: (2017)

The Innate Antiviral Response in Animals: An Evolutionary Perspective from Flagellates to Humans
por: Majzoub, Karim, et al.
Publicado: (2019)

Editorial: Current Progress and Challenges in the Development of a B Cell Based Hepatitis C Virus Vaccine
por: Foung, Steven K. H., et al.
Publicado: (2018)

Hepatitis C Virus NS3 Inhibitors: Current and Future Perspectives
por: Salam, Kazi Abdus, et al.
Publicado: (2013)

Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976
por: Hofmann-Winkler, Heike, et al.
Publicado: (2015)

The Current Host Range of Hepatitis E Viruses
por: Kenney, Scott P
Publicado: (2019)

Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia
por: McDonald, Scott A., et al.
Publicado: (2015)

Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C
por: Xiao, Fei, et al.
Publicado: (2015)

Addressing the Challenges of Hepatitis C Virus Resistance and Treatment Failure
por: Colpitts, Che C., et al.
Publicado: (2016)

Clearance of persistent hepatitis C virus infection using a claudin-1-targeting monoclonal antibody
por: Mailly, Laurent, et al.
Publicado: (2015)

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies
por: Duong, Francois H.T., et al.
Publicado: (2014)

Liver Disease and Coronavirus Disease 2019: From Pathogenesis to Clinical Care
por: Saviano, Antonio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nt4cdc56o15ji6hh0msmfgl0a5